美股市場個股詳情

AMGN 安進

添加自選

311.290
+32.900+11.82%

收盤價 05/03 16:00 (美東)

311.400
+0.110+0.04%

盤後 19:41 (美東)

1669.68億總市值44.47市盈率TTM

安進股票討論區

登錄發表評論

Kevin Travers

7小時前

專欄Finally Friday, Finally May. Higher Unemployment? Investors say 'Buy Now' | Market Moovers

Morning mooers! It is Friday, May 3rd, and the market green after a jam-packed Q1 earnings week.
This time around, FOMC nonaction and low jobs numbers helped push equities in the green, or it migh just be because April is finally over. My name is Kevin Travers, here are stories moving the market:
MOOVERS
$Amgen (AMGN.US)$'s stock soared 12% toward biggest gain in 15 years, adding more than 220 points to the...

TanKH

8小時前

Short term trade

$安進(AMGN.US)$
It has been a while since I last traded.
3 days effort. Thank you Amgen

曬曬你今日的盈虧

Movers and Shakers

10小時前

專欄Today's Morning Movers and Top Ratings: AAPL, AMGN, SQ, NET and More

Morning Movers
Gapping up
$蘋果(AAPL.US)$ rose by 7% after the company reported a decline in revenue in the first quarter of the year but still exceeded analysts' projections. The tech giant also announced a $110 billion stock buyback program and raised its dividend by 4%.
$安進(AMGN.US)$ soared by 13% after the company expressed encouragement upon completing an interim analysis of its mid-stage study of the weight-loss drug M...

Moomoo Breakfast US

11小時前

專欄Morning News Call | Dow Futures Jump 500 Points as Weak Jobs Report Sends Yields Lower

Friday, May 3
Before the Bell U.S.
Stock futures jumped sharply Friday after a softer-than-expected April jobs report boosted hopes that the Federal Reserve could start cutting interest rates soon.
Futures tied to the $道瓊斯指數(.DJI.US)$ gained 502 points, or 1.3%. $標普500指數(.SPX.US)$ futures rose 1.1%, while $納斯達克100指數(.NDX.US)$ futures advanced about 1.6%.
Top News
U.S. Job Gro...

nerdbull1669

18小時前

Market Optimistic Amid Uncertainty Over Rate Cut Decision

We saw yesterday’s trading session maintaining a positive tone from start to finish, gaining momentum in the afternoon.
The Dow Jones Industrial Average saw an increase of 0.9%, while the S&P 500 also rose by 0.9%. The Nasdaq Composite experienced a more significant boost, climbing 1.5%, and the Russell 2000 outperformed with a 1.8% increase.
We have Coinbase and Block releasing their earnings after hours and they lead the earnings surpris...

大型科技股走勢各異，能否持續為市場帶來信心？

life is a blessing

04/12 10:50

ESPR is the Probably the Most Undervalued Stock on the Market, Offers 2500% Upside. 2 FDA Approved Blockbuster Drugs. Billions in Sales Expected. Buyout Expected.

$Esperion Therapeutics(ESPR.US)$ Esperion (ESPR) stock price has dropped from a recent high of $3.40 a share to $2.31 on FALSE claims of dilution. The price drop offers an amazing buying opportunity.
Huge News On Mar 25.2024 U.S. FDA Approved Broad Labels for NEXLIZET and NEXLETOL, now regular doctors can prescribe and Insurance will...

Carla Lee

04/01 22:31

what is your best undervalued stocks?

Investors subscribing to the value investing approach believe it's possible to identify stocks that are trading at a price below their intrinsic value. The idea is that, by investing in these companies before the market corrects, one stands to experience gains when the price of the stock increases to match the true value.
For March 2024, the most undervalued stocks—those with the lowest price-to-earnings (P/E) ratios for each sector—include energy transportat...

PREMOSULTRAA

03/08 11:47

OBESITY Will only focus on main players $VKTX $LLY $NVO $AMGN $GPCR

$Viking Therapeutics(VKTX.US)$$禮來(LLY.US)$$諾和諾德(NVO.US)$$安進(AMGN.US)$$碩迪生物(GPCR.US)$
Demand is too high for the obesity drugs but major drug companies unable to keep up with this demand. This will be an opportunity for multiple drug companies to take a pie out of the obesity market.
SubQ likely to be prescribed first for short term weight loss and oral drugs for maintenance. This is not an oncology space ...

Moomoo AI

03/01 02:50

Disney, Fox Corp-B, and Warner Bros Discovery's joint venture faces a lawsuit by FuboTV on antitrust grounds. Amgen's weak performance is due to mixed financial forecasts and questions about its weight-loss drug, MariTide. Constellation Energy's strong performance is backed by the IRA's nuclear production tax credit and effective cash flow deployment. Charter Communications' poor performance is due to a surprise loss in internet subscribers and missed quarterly earnings expectations.